| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |